Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double Blind, Double Dummy, Randomised, Multicentre, Two Arm Parallel Group Study to Assess the Efficacy and Safety of FLUTIFORM® pMDI (2 Puffs Bid) vs Seretide® pMDI (2 Puffs Bid) in Subjects Aged ≥12 Years With Moderate to Severe Persistent, Reversible Asthma
Brief Summary: A double blind, double dummy, randomised, multicentre, two arm parallel group study to assess the efficacy and safety of FLUTIFORM® pMDI (2 puffs bid) vs Seretide® pMDI (2 puffs bid) in subjects aged ≥12 years with moderate to severe persistent, reversible asthma.


Options:
A: Arm Label: Fluticasone/ Formoterol (Flutiform); Type: EXPERIMENTAL; Interventions: Drug: Fluticasone/ Formoterol | Arm Label: Fluticasone/ salmeterol (Seretide); Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone/ salmeterol | Intervention Type: DRUG; Name: Fluticasone/ Formoterol; Assigned to Arm(s): Fluticasone/ Formoterol (Flutiform) | Intervention Type: DRUG; Name: fluticasone/ salmeterol; Assigned to Arm(s): Fluticasone/ salmeterol (Seretide)
B: Arm Label: FLAMBOYANT 200/12; Type: EXPERIMENTAL; Interventions: Drug: Flamboyant 200/12, Other: Budesonide / Formoterol 400/12 Placebo | Arm Label: Budesonide/formoterol 400/12; Type: ACTIVE_COMPARATOR; Interventions: Drug: Budesonide / Formoterol 400/12, Other: Flamboyant 200/12 Placebo | Intervention Type: DRUG; Name: Flamboyant 200/12; Assigned to Arm(s): FLAMBOYANT 200/12 | Intervention Type: DRUG; Name: Budesonide / Formoterol 400/12; Assigned to Arm(s): Budesonide/formoterol 400/12 | Intervention Type: OTHER; Name: Flamboyant 200/12 Placebo; Assigned to Arm(s): Budesonide/formoterol 400/12 | Intervention Type: OTHER; Name: Budesonide / Formoterol 400/12 Placebo; Assigned to Arm(s): FLAMBOYANT 200/12
C: Arm Label: Sequence 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVM149 150/50/80 μg o.d., Drug: QVM149 150/50/160 μg o.d., Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d. | Arm Label: Sequence 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVM149 150/50/80 μg o.d., Drug: QVM149 150/50/160 μg o.d., Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d. | Arm Label: Sequence 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVM149 150/50/80 μg o.d., Drug: QVM149 150/50/160 μg o.d., Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d. | Arm Label: Sequence 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVM149 150/50/80 μg o.d., Drug: QVM149 150/50/160 μg o.d., Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d. | Arm Label: Sequence 5; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVM149 150/50/80 μg o.d., Drug: QVM149 150/50/160 μg o.d., Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d. | Arm Label: Sequence 6; Type: ACTIVE_COMPARATOR; Interventions: Drug: QVM149 150/50/80 μg o.d., Drug: QVM149 150/50/160 μg o.d., Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d. | Intervention Type: DRUG; Name: QVM149 150/50/80 μg o.d.; Assigned to Arm(s): Sequence 1, Sequence 2, Sequence 3, Sequence 4, Sequence 5, Sequence 6 | Intervention Type: DRUG; Name: QVM149 150/50/160 μg o.d.; Assigned to Arm(s): Sequence 1, Sequence 2, Sequence 3, Sequence 4, Sequence 5, Sequence 6 | Intervention Type: DRUG; Name: salmeterol/fluticasone FDC 50/500 μg b.i.d.; Assigned to Arm(s): Sequence 1, Sequence 2, Sequence 3, Sequence 4, Sequence 5, Sequence 6
D: Arm Label: GP MDI 28.8 μg; Type: EXPERIMENTAL; Interventions: Drug: GP MDI 28.8 μg | Arm Label: GP MDI 14.4 μg; Type: EXPERIMENTAL; Interventions: Drug: GP MDI 14.4 μg | Arm Label: GP MDI 7.2 μg; Type: EXPERIMENTAL; Interventions: Drug: GP MDI 7.2 μg | Arm Label: Placebo MDI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo MDI | Arm Label: Spiriva Respimat 2.5 μg; Type: OTHER; Interventions: Drug: Spiriva Respimat 2.5 μg | Intervention Type: DRUG; Name: GP MDI 28.8 μg; Assigned to Arm(s): GP MDI 28.8 μg | Intervention Type: DRUG; Name: GP MDI 14.4 μg; Assigned to Arm(s): GP MDI 14.4 μg | Intervention Type: DRUG; Name: GP MDI 7.2 μg; Assigned to Arm(s): GP MDI 7.2 μg | Intervention Type: DRUG; Name: Placebo MDI; Assigned to Arm(s): Placebo MDI | Intervention Type: DRUG; Name: Spiriva Respimat 2.5 μg; Assigned to Arm(s): Spiriva Respimat 2.5 μg

Answer: A